PFIZER LIMITED : CLARIFICATION ON NEWS ITEM

• The company stated that Premarin Vaginal Cream, an imported product, has been temporarily discontinued in India due to supply constraints. • Pfizer is actively exploring options to restore the supply at the earliest. • The temporary discontinuation is not expected to have any material impact on the Company's financial performance, business operations or profitability, as Premarin Vaginal Cream contributes less than 1% to the company's revenue. • This discontinuation did not constitute a material event requiring disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015. Impact: The temporary discontinuation of Premarin Vaginal Cream is not expected to materially impact the company's financial performance.

Pfizer Limited

Open attachment

← Back to feed